- Buprenorphine 160mg/0.45ml prolonged-release solution for injection pre-filled syringes
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Buprenorphine 160mg/0.45ml prolonged-release solution for injection pre-filled syringes | Start Date 25-02-2022 | End Date |
Abbreviated Name | Abbreviated Name Buprenorphine 160mg/0.45ml prolonged-release inj pf syringes | Start Date 25-02-2022 |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 0.45
- UDFS UOM
- ml
- Unit Dose UOM
- pre-filled disposable injection
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 3 (CD No Register)
- Route
- Subcutaneous
- Form
- Prolonged-release solution for injection
- Ontology Form/Route
- solutioninjectionprolonged-release.subcutaneous
- Name Basis
- INNM - International Non-proprietary Name (Modified)
Codes
- ATC Code
- N02AE01
- BNF Codes
-
- BNF code 04100300
Code | Start Date | End Date |
---|---|---|
40558011000001102 | 25-02-2022 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Buprenorphine | Based on Ingredient Substance | 355.56 mg | 1 ml |
Name
Buprenorphine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
355.56
Strength and UOM (Dmr)
1
Parent Products
-
VTMBuprenorphine
-
VMP(Current) Buprenorphine 160mg/0.45ml prolonged...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 pre-filled disposable injection | 23970 | Part VIIIA Category C |